Accredited E-Newsletter Series

Risk-Stratified Treatment Strategies for Lower-Risk MDS
Risk-Stratified Treatment Strategies for Lower-Risk MDS
CME, CPE
Caroline Helwick, Medical Writer
Release Date: September 27, 2016
Expiration Date: September 27, 2017
The management of patients with myelodysplastic syndrome (MDS) is based on stratification into various risk categories. For patients with lower-risk MDS, treatment goals and therapeutic paradigms differ from those of intermediate- and higher-risk MDS patients. This activity will review the management of patients with lower-risk MDS, including considerations for initiating therapy, treatment options based on patient assessment, and risk-stratification and supportive care measures to address cytopenias.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
View Only, CE ExpiredView Only, No Credit
 
Assessing the Elderly MDS Patient for Comorbidities, Frailty and Treatment Fitness
Assessing the Elderly MDS Patient for Comorbidities, Frailty and Treatment Fitness
CME, CPE
Caroline Helwick, Medical Writer
Release Date: June 22, 2016
Expiration Date: June 22, 2017
Myelodysplastic syndrome is largely a disease of the elderly, as the median age at diagnosis is 71. Comorbidities and frailty, therefore, are frequent observations in this patient population that can complicate the assessment of “risk” and impact treatment intensity. The elderly MDS patient’s overall health must be considered when prognosticating survival and treatment tolerance. Validated tools are available to help clinicians in this effort. This CE activity explores the issue of treatment fitness, and offers resources to help clinicians assess risk and design appropriate treatment strategies.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
View Only, CE ExpiredView Only, No Credit
 
Case Study: Predicting the Course of Treatment in an Elderly Patient with Refractory Anemia
Case Study: Predicting the Course of Treatment in an Elderly Patient with Refractory Anemia
CME, CPE
Tania Dickson, PhD, and Eugene R. Tombler, PhD, FACME
Release Date: February 24, 2016
Expiration Date: February 24, 2017
This MDS Quarterly e-Newsletter incorporates a case vignette that illustrates the use of current diagnostic tests and prognostic scoring systems in daily clinical practice as well as addresses the practical aspects of delivering prognostic information to patients and/or their caregivers.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
View Only, CE ExpiredView Only, No Credit
 
Practical Applications of the IPSS-R in MDS
Practical Applications of the IPSS-R in MDS
CME, CPE
Tania Dickson, PhD, and Eugene R. Tombler, PhD, FACME
Release Date: December 10, 2015
Expiration Date: December 10, 2016
This MDS Quarterly e-Newsletter focuses on the role of the Revised International Prognostic Scoring System (IPSS-R) in daily clinical practice, specifically with regard to identifying prognosis for individual patients and selecting treatment based on prognostic score. This activity also addresses the practical aspects of delivering prognostic information to patients and/or their caregivers.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
View Only, CE ExpiredView Only, No Credit
 

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved